IRIDEX (IRIX) SEC Filings: History & Chart

IRIDEX Corporation(IRIX)

Medical - Devices · Mountain View, CA

$0.68-0.01 (-1.45%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About IRIDEX Corporation

IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment. For ailments like diabetic macular edema and other retinal pathologies, IRIDEX provides the IQ 532 and IQ 577 laser photocoagulation systems. Furthermore, the OcuLight series, encompassing models such as TX, SL, SLx, GL, and GLx, offers solutions for managing severe retinal issues like proliferative diabetic retinopathy, macular holes, and retinal tears or detachments. Beyond laser consoles, the company also manufactures specialized delivery instruments. These include the TxCell scanning laser delivery system, which empowers clinicians with multi-spot pattern scanning capabilities. A unique slit lamp adapter enables practitioners to integrate standard slit lamps into their diagnostic and therapeutic workflows. Additionally, a laser indirect ophthalmoscope is available for interventions targeting peripheral retinal disorders. IRIDEX's offerings extend to various probes. The MicroPulse P3 Probe, when coupled with the Cyclo G6 laser system, facilitates MicroPulse transscleral laser therapy. For managing uncontrolled glaucoma, the G-Probe is employed, while both the G-Probe and G-Probe Illuminate are utilized in procedures addressing refractory glaucoma. The EndoProbe product line supports a range of vitrectomy procedures. Their diverse client base spans ophthalmology professionals, academic and research hospitals, government healthcare facilities, specialized surgical centers, general hospitals, veterinary clinics, and private medical practices. Product distribution is handled via an internal and independent sales network across the United States, supplemented by independent distributors for its international markets. Originally incorporated in 1989 as IRIS Medical Instruments, Inc., the company adopted the name IRIDEX Corporation in November 1995. Its corporate headquarters are situated in Mountain View, California.

Mountain View, CA

93 employees

www.iridex.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Patrick Mercer

View full financials

Form	Filing Date	Accepted	Document
4	Oct 5, 2026	Oct 5, 2026	View filing
4	Sep 16, 2026	Sep 16, 2026	View filing
4	Sep 14, 2026	Sep 14, 2026	View filing
4	Sep 10, 2026	Sep 10, 2026	View filing
8-K	Sep 2, 2026	Sep 2, 2026	View filing
4	Aug 24, 2026	Aug 24, 2026	View filing
10-Q	Aug 18, 2026	Aug 18, 2026	View filing
8-K	Aug 18, 2026	Aug 18, 2026	View filing
8-K	Jul 16, 2026	Jul 16, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
SC 13D/A	Jul 13, 2026	Jul 13, 2026	View filing
4	Jul 8, 2026	Jul 8, 2026	View filing
8-K	Jun 18, 2026	Jun 18, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 3, 2026	Jun 3, 2026	View filing
SD	Jun 1, 2026	Jun 1, 2026	View filing
4	May 26, 2026	May 26, 2026	View filing
4	May 26, 2026	May 26, 2026	View filing
10-Q	May 19, 2026	May 19, 2026	View filing
8-K	May 19, 2026	May 19, 2026	View filing
ARS	Apr 24, 2026	Apr 24, 2026	View filing
DEFA14A	Apr 24, 2026	Apr 24, 2026	View filing
DEF 14A	Apr 24, 2026	Apr 24, 2026	View filing
D/A	Apr 3, 2026	Apr 3, 2026	View filing

SEC Filings

Recent Filings